World Autoimmune Arthritis Day: Understanding Autoimmune Arthritis

Autoimmune arthritis is a chronic inflammatory disease that affects millions of people worldwide, including a large population in India. Rheumatoid arthritis (RA), psoriatic arthritis (PsA), and ankylosing spondylitis (AS) are the most common types of autoimmune arthritis. This article provides a comprehensive overview of autoimmune arthritis in India, exploring its symptoms, diagnosis, treatment options, and the unique challenges faced by patients in the Indian healthcare landscape.

India faces several unique challenges in the management of autoimmune arthritis. Limited awareness and understanding of the disease among the general population often results in delayed diagnosis and treatment. Additionally, the availability and accessibility of specialist rheumatology services, including trained healthcare professionals and diagnostic facilities, remains inadequate in many areas.

Unsplash/Representative Image

While specific statistics on the prevalence of autoimmune arthritis in India are limited, studies suggest that RA affects approximately 0.5-1% of the Indian population. However, data regarding the prevalence of other autoimmune arthritic conditions such as PA and AS are scarce.

Autoimmune arthritis encompasses a group of chronic inflammatory diseases in which the immune system mistakenly attacks the body’s own joints, leading to inflammation, pain, and potential joint damage. Here are the main symptoms of autoimmune arthritis:

1. Joint pain and stiffness: Persistent pain and stiffness in the affected joints are common symptoms. The pain is usually worse in the morning or after periods of inactivity. It can be described as painful, throbbing or sharp, and it can affect one or more joints.

2. Joint swelling and redness: Affected joints often show swelling, tenderness and redness. The swelling is the result of inflammation and can cause visible enlargement or swelling around the joints.

Unsplash/Representative Image

3. Fatigue: Many people with autoimmune arthritis experience persistent fatigue, which can be overwhelming and affect daily functioning. The exact cause of fatigue in autoimmune arthritis is not fully understood, but may be related to underlying inflammatory processes or associated conditions like anemia.

4. Reduced range of motion: Autoimmune arthritis can cause decreased flexibility and limited range of motion in affected joints. Joint stiffness, along with pain and swelling, can make it difficult for joints to move freely.

5. Systemic Symptoms: In addition to joint-related symptoms, some people may experience systemic manifestations such as fever, unintended weight loss, and generally feeling unwell. These systemic symptoms may occur especially during periods of active disease flare-ups.

Accurate diagnosis is crucial for effective management of autoimmune arthritis. A combination of medical history, physical exam, blood tests, imaging studies, and analysis of synovial fluid helps diagnose the condition. In India, healthcare professionals are facing challenges due to limited access to specialized rheumatology services, leading to delayed diagnosis and treatment initiation for many patients.

Unsplash/Representative Image

Treatment options for autoimmune arthritis aim to reduce symptoms, control inflammation, slow disease progression, and improve the overall quality of life for people with these conditions. The specific treatment plan will depend on the type and severity of autoimmune arthritis, as well as individual factors such as general health, age, and personal preference. Here are some common treatment options for autoimmune arthritis:

1. Medicines:

Nonsteroidal anti-inflammatory drugs (NSAIDs): These medications, available over the counter or by prescription, help reduce joint pain and inflammation. They can provide temporary relief and are often used as first-line treatment.

Disease-modifying anti-rheumatic drugs (DMARDs): DMARDs are the mainstay of treatment for autoimmune arthritis. They work by suppressing the immune system to slow disease progression and prevent joint damage. Methotrexate is a commonly prescribed DMARD, but other options like sulfasalazine, leflunomide, and hydroxychloroquine can also be used.

Biological Response Modifiers: Biologics are a new class of drugs that specifically target immune system proteins and pathways involved in autoimmune arthritis. They are usually prescribed for moderate to severe cases that do not respond adequately to conventional DMARDs. Examples include tumor necrosis factor (TNF) inhibitors, interleukin inhibitors and Janus kinase (JAK) inhibitors.

Unsplash/Representative Image

2. Physiotherapy and exercise:

Physiotherapy: Working with a physiotherapist can help improve joint mobility, strengthen the muscles supporting the joints, and improve overall physical function. Therapists can recommend specific exercises, stretching techniques, and assistive devices to manage symptoms.

Low-impact exercises: Regularly engaging in low-impact exercises like swimming, cycling, and walking can help improve joint flexibility, maintain muscle strength, and reduce pain. It’s important to balance physical activity with rest and avoid high-impact activities that can make joint symptoms worse.

3. Lifestyle changes:

Rest and Joint Protection: A balance of activity and rest is key to managing symptoms and preventing joint damage. Avoiding repetitive motions and using assistive devices, such as braces or splints, can help protect joints during daily activities.

Unsplash/Representative Image

Weight Management: Maintaining a healthy weight is key to reducing pressure on joints and relieving symptoms. Losing excess weight can dramatically improve joint function and decrease pain.

Heat and cold therapy: Applying hot or cold compresses to affected joints can provide temporary relief and help reduce inflammation and pain.

Autoimmune arthritis is a huge burden in India, affecting many people and posing unique challenges. Raising awareness, improving access to specialist rheumatology services and ensuring affordable treatment options are essential steps towards better management of autoimmune arthritis in the country. Collaboration between healthcare providers, policymakers, patient advocacy groups and the pharmaceutical industry is needed to address these challenges and improve the lives of people with autoimmune arthritis in India. Through concerted efforts, it is possible to achieve early diagnosis, effective treatment and improved quality of life for patients with autoimmune arthritis across the country.

About the Author: Dr. Naman Jain is Consultant in Clinical Immunology and Rheumatology at Ramkrishna CARE Hospitals, Raipur. All views/opinions expressed in the article are by the author.